Results 151 to 160 of about 24,931 (209)

3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids infused into the peritoneal cavity cannot be found in plasma. [Elektronisk resurs]

open access: yes, 2009
OBJECTIVE: Glucose degradation products (GDPs) are important for the outcome of peritoneal dialysis (PD) treatment. The most cytotoxic GDP found in conventionally manufactured fluids, 3,4-dideoxyglucosone-3-ene (3,4-DGE), may in addition be recruited ...
Carlsson, Ola,   +7 more
core  

Chronic peritoneal dialysis in children

open access: yes, 2015
Nia Fraser,1 Farida K Hussain,2 Roy Connell,3 Manoj U Shenoy1 1Department of Paediatric Urology, 2Paediatric Nephrology, 3Paediatric Dialysis, Nottingham University Hospitals NHS Trust, Nottingham, UK Abstract: The incidence of end-stage renal disease ...
Shenoy MU   +3 more
core  

Peritoneal homocysteine clearance is inefficient in peritoneal dialysis patients

open access: yes, 2000
Objectives: To investigate the degree and the determinants of peritoneal homocysteine (Hcy) clearance and to compare measured Hey clearance with the Hey clearance predicted based on molecular weight (MW).
Campbell, Scott B.   +5 more
core  

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

ADVANCES IN PERITONEAL DIALYSIS

open access: yes, 1999
Elmas, Bahri   +6 more
core  

WCN24-2144 THE BRAZILIAN RANDOMIZED CONTROLLED UNBLINDED PILOT TRIAL OF URGENT START PERITONEAL DIALYSIS – THE BRUTUS TRIAL INITIAL RESULTS

open access: yesKidney International Reports
Helena Balbé   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy